Brief: Vaccinex, Inc. Announces Reverse Stock Split
15/02/2024 13:48
Feb 15 (Reuters) - Vaccinex Inc VCNX.O :
* VACCINEX, INC. ANNOUNCES REVERSE STOCK SPLIT
* WILL EFFECT A 1-FOR-14 REVERSE STOCK SPLIT OF ITS ISSUED
COMMON
STOCK
* BEGINNING FEBRUARY 20, COMMON STOCK WILL TRADE ON A
SPLIT-ADJUSTED BASIS
* IMPLEMENTED REVERSE STOCK SPLIT WITH OBJECTIVE OF
REGAINING
COMPLIANCE WITH $1.00 MINIMUM BID PRICE REQUIREMENT OF NASDAQ
Source text for Eikon: ID:nGNX1VbtD4
Further company coverage: VCNX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Vaccinex
See all newsBrief: Vaccinex Reports Third Quarter 2024 Financial Results And Provides Corporate Update
Brief: Vaccinex Says On Oct 7, Got Letter From The Nasdaq Listing Staff Stating That Co Had Not Regained Compliance With The Equity Standard
Brief: VaccinexExercise Of Warrants For $6.2 Million In Gross Proceeds
Brief: Vaccinex Provides Update On New Findings For Signal-Ad Phase 1B/2 Trial Of Pepinemab In Alzheimer’S Disease
Brief: Vaccinex Reports Completion of Last Patient Visit in Randomized, SIGNAL-AD Phase 1b/2 Study of Pepinemab Treatment for Alzheimer’s Disease